TABLE 2.

Frequency of Consequences by Group Before and After Possible Melanoma Screening by INFORMED-Trained PCPs

		January to August 2013	January to August 2014	Increase From 2013 to 2014 (95% CI)	Proportion Increase From 2013 to 2014
Skin surgeries	Group A1	7.39% (831/11,238)	7.54% (947/12,560)	0.15% (−0.52 to 0.81)	0.020
	Group A2	6.21% (212/3414)	6.47% (253/3913)	0.26% (−0.86 to 1.37)	0.042
	Group B	5.84% (3088/52,908)	5.84% (3282/56,261)	0.00% (−0.28 to 0.28)	0
Dermatology visits	Group A1	17.31% (1945/11,238)	17.74% (2228/12,560)	0.43% (−0.54 to 1.40)	0.025
	Group A2	14.65% (500/3414)	16.15% (632/3913)	1.50% (−0.15 to 3.16)	0.102
	Group B	11.09% (5868/52,908)	11.58% (6515/56,261)	0.49% (0.11 to 0.87)	0.044
Melanoma diagnoses per 10,000	Group A1	21.36 (24/11,238)	38.22 (48/12,560)	16.86 (3.10 to 30.62)	0.789
	Group A2	26.36 (9/3414)	25.56 (10/3913)	−0.80 (−24.17 to 22.56)	−0.030
	Group B	20.41 (108/52,908)	21.86 (123/56,261)	1.45 (−4.00 to 6.90)	0.071

Abbreviations: 95% CI, 95% confidence interval; INFORMED, INternet course FOR Melanoma Early Detection; PCP, primary care provider.